Analystreport

Proteon Therapeutics (NASDAQ: PRTO) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.

PROTEON THERAPEUTICS  (PRTO) 
Last proteon therapeutics earnings: 8/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.proteontherapeutics.com